Literature DB >> 32810354

Primary aldosteronism: Involvement of sympathetic system in the persistence of hypertension after surgery.

Decio Armanini1, Chiara Sabbadin1, Alessandra Andrisani2, Guido Ambrosini2, Luciana Bordin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32810354      PMCID： PMC8030013          DOI： 10.1111/jch.13964

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  12 in total

1.  Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate.

Authors:  Decio Armanini; Cristina Fiore; Donatella Pellati
Journal:  Hypertension       Date:  2007-08-20       Impact factor: 10.190

2.  Enigma of the Origin of Primary Aldosteronism.

Authors:  Decio Armanini; Chiara Sabbadin; Luciana Bordin
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

3.  Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.

Authors:  Tracy Ann Williams; Diana Jaquin; Jacopo Burrello; Aurélie Philippe; Yuhong Yang; Petra Rank; Nina Nirschl; Lisa Sturm; Christoph Hübener; Duska Dragun; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  Hypertension       Date:  2019-09-03       Impact factor: 10.190

4.  Mineralocorticoid receptor is involved in the aldosterone pathway in human red blood cells.

Authors:  Luciana Bordin; Carlo Saccardi; Gabriella Donà; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Mario Plebani; Anna Maria Brunati; Eugenio Ragazzi; Salvatore Gizzo; Decio Armanini
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

6.  Human red blood cells alterations in primary aldosteronism.

Authors:  Luciana Bordin; Gabriella Donà; Chiara Sabbadin; Eugenio Ragazzi; Alessandra Andrisani; Guido Ambrosini; Anna Maria Brunati; Giulio Clari; Decio Armanini
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

7.  Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.

Authors:  Lorenzo A Calò; Francesca Zaghetto; Elisa Pagnin; Paul A Davis; Paola De Mozzi; Paola Sartorato; Giuseppe Martire; Cristina Fiore; Decio Armanini
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

8.  Rapid nongenomic effects of aldosterone on the renal vasculature in humans.

Authors:  Bernhard M W Schmidt; Ulla Sammer; Ingrid Fleischmann; Markus Schlaich; Christian Delles; Roland E Schmieder
Journal:  Hypertension       Date:  2006-03-06       Impact factor: 10.190

9.  Primary aldosteronism: Involvement of sympathetic system in the persistence of hypertension after surgery.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

10.  Clinical outcomes of laparoscopic-based renal denervation plus adrenalectomy vs adrenalectomy alone for treating resistant hypertension caused by unilateral aldosterone-producing adenoma.

Authors:  Yahui Liu; Binbin Zhu; Lijie Zhu; Linwei Zhao; Degang Ding; Zhonghua Liu; Zhiqiang Fan; Qiuping Zhao; You Zhang; Jiguang Wang; Chuanyu Gao
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738
View more
  1 in total

1.  Primary aldosteronism: Involvement of sympathetic system in the persistence of hypertension after surgery.

Authors:  Decio Armanini; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.